GT Biopharma, Inc. (GTBP)
Nasdaq: GTBP · CIK 0000109657 · United States
Every official GT Biopharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open GTBP filings
GT Biopharma, Inc. documents
- GT Biopharma, Inc. 10-K 2026GTBP 10-K 2026: annual report for fiscal 2026
- GT Biopharma, Inc. 10-K 2025GTBP 10-K 2025: annual report for fiscal 2025
- GT Biopharma, Inc. 10-K 2024GTBP 10-K 2024: annual report for fiscal 2024
- GT Biopharma, Inc. 10-K 2023GTBP 10-K 2023: annual report for fiscal 2023
- GT Biopharma, Inc. 10-K 2022GTBP 10-K 2022: annual report for fiscal 2022
- GT Biopharma, Inc. 10-Q 2026GTBP 10-Q 2026: quarterly report for fiscal 2026
- GT Biopharma, Inc. 10-Q 2025GTBP 10-Q 2025: quarterly report for fiscal 2025
- GT Biopharma, Inc. 10-Q 2024GTBP 10-Q 2024: quarterly report for fiscal 2024
- GT Biopharma, Inc. 10-Q 2023GTBP 10-Q 2023: quarterly report for fiscal 2023
- GT Biopharma, Inc. 10-Q 2022GTBP 10-Q 2022: quarterly report for fiscal 2022
- GT Biopharma, Inc. 8-K 2026GTBP 8-K 2026: current report for fiscal 2026
- GT Biopharma, Inc. 8-K 2025GTBP 8-K 2025: current report for fiscal 2025
- GT Biopharma, Inc. 8-K 2024GTBP 8-K 2024: current report for fiscal 2024
- GT Biopharma, Inc. 8-K 2023GTBP 8-K 2023: current report for fiscal 2023
- GT Biopharma, Inc. 8-K 2022GTBP 8-K 2022: current report for fiscal 2022
- GT Biopharma, Inc. DEF 14A 2026GTBP DEF 14A 2026: proxy statement for fiscal 2026
- GT Biopharma, Inc. DEF 14A 2025GTBP DEF 14A 2025: proxy statement for fiscal 2025
- GT Biopharma, Inc. DEF 14A 2024GTBP DEF 14A 2024: proxy statement for fiscal 2024
- GT Biopharma, Inc. DEF 14A 2023GTBP DEF 14A 2023: proxy statement for fiscal 2023
- GT Biopharma, Inc. DEF 14A 2022GTBP DEF 14A 2022: proxy statement for fiscal 2022
- GT Biopharma, Inc. Form 4 2026GTBP Form 4 2026: insider trading filing for fiscal 2026
- GT Biopharma, Inc. Form 4 2025GTBP Form 4 2025: insider trading filing for fiscal 2025
- GT Biopharma, Inc. Form 4 2024GTBP Form 4 2024: insider trading filing for fiscal 2024
- GT Biopharma, Inc. Form 4 2023GTBP Form 4 2023: insider trading filing for fiscal 2023
- GT Biopharma, Inc. Form 4 2022GTBP Form 4 2022: insider trading filing for fiscal 2022
- GT Biopharma, Inc. S-1 2026GTBP S-1 2026: registration statement for fiscal 2026
- GT Biopharma, Inc. S-1 2025GTBP S-1 2025: registration statement for fiscal 2025
- GT Biopharma, Inc. S-1 2024GTBP S-1 2024: registration statement for fiscal 2024
- GT Biopharma, Inc. S-1 2023GTBP S-1 2023: registration statement for fiscal 2023
- GT Biopharma, Inc. S-1 2022GTBP S-1 2022: registration statement for fiscal 2022
- GT Biopharma, Inc. 13F 2026GTBP 13F 2026: institutional holdings for fiscal 2026
- GT Biopharma, Inc. 13F 2025GTBP 13F 2025: institutional holdings for fiscal 2025
- GT Biopharma, Inc. 13F 2024GTBP 13F 2024: institutional holdings for fiscal 2024
- GT Biopharma, Inc. 13F 2023GTBP 13F 2023: institutional holdings for fiscal 2023
- GT Biopharma, Inc. 13F 2022GTBP 13F 2022: institutional holdings for fiscal 2022
More companies